Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

543

Participants

Timeline

Start Date

May 8, 2019

Primary Completion Date

October 20, 2023

Study Completion Date

October 20, 2023

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Sacituzumab Govitecan-hziy

Administered intravenously

DRUG

Eribulin

Administered intravenously per NCCN guidelines

DRUG

Capecitabine

Administered orally per NCCN guidelines

DRUG

Gemcitabine

Administered intravenously per NCCN guidelines

DRUG

Vinorelbine

Administered intravenously per NCCN guidelines

Trial Locations (113)

1066

Antoni van Leeuwenhoekziekenhuis, Amsterdam

6229

Maastricht UMC+, Maastricht

10016

Laura and Isaac Perlmutter Cancer Center/NYU Langone Health, New York

10029

Icahn School of Medicine at Mount Sinai, New York

10032

Columbia University Medical Center, New York

10065

Memorial Sloan Kettering Cancer Center, New York

12002

Hospital Provincial de Castellón, Castillón

12206

New York Oncology Hematology, P.C., Albany

13125

HELIOS Klinikum Berlin-Buch, Berlin

15006

Complejo Hospitalario Universitario A Coruna, A Coruña

15213

Magee-Womens Hospital of UPMC, Pittsburgh

15706

Hospital Clinico Universitario de Santiago de Compostela, Santiago de Compostela

19107

Thomas Jefferson University, Philadelphia

20007

Georgetown University Medical Center, Washington D.C.

20132

Ospedale San Raffaele, Milan

20249

Onkologische Schwerpunktpraxis Eppendorf, Hamburg

20832

Ospedale di Desio, Desio

20850

Maryland Oncology Hematology, P.A., Rockville

21000

Centre Georges-Francois Leclerc, Dijon

21202

Mercy Medical Center, Medical Oncology & Hematology, Baltimore

22205

Virginia Cancer Specialists, Arlington

23502

Virginia Oncology Associates, Norfolk

24153

Oncology & Hematology Associates of Southwest Virginia, Inc. DBA Blue Ridge Cancer Care, Salem

25030

Hôpital Jean-Minjoz, Besançon

25198

Hospital Universitari Arnau de Vilanova, Lleida

28007

Hospital General Universitario Gregorio Maranon, Madrid

28034

Instituto Oncologico Bureau (IOB), Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

29121

Azienda Unità Sanitaria Locale di Piacenza-Ospedale Guglielmo da Saliceto, Piacenza

30177

Gynakologisch-Onkologische Praxis Hannover, Hanover

30322

Emory University - Winship Cancer Institute, Atlanta

30342

Northside Hospital, Inc., Atlanta

31300

Institut Claudius Regaud, Toulouse

32806

Orlando Health, Inc., Orlando

33136

University of Miami - Sylvester Comprehensive Cancer Center, Miami

33176

Miami Cancer Institute, Miami

33612

Moffitt Cancer Center, Tampa

34298

Institut Régional du Cancer de Montpellier, Montpellier

37203

Tennessee Oncology, PLLC, Nashville

37232

Vanderbilt University Medical Center, Nashville

38138

The West Clinic, PC dba West Cancer Center, Germantown

40202

James Graham Brown Cancer Center, Louisville

41013

Hospital Universitario Virgen del Rocio, Seville

42271

Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez

43210

The Ohio State University, Columbus

45136

Kliniken Essen-Mitte, Essen

46236

Marienhospital Bottrop, Bottrop

53111

Gynakologisches Zentrum Bonn, Bonn

55407

Allina Health, Virginia Piper Cancer Institute, Minneapolis

55455

Masonic Cancer Center, University of Minnesota, Minneapolis

56068

Praxisklinik für Hämatologie und Onkologie Koblenz, Koblenz

57245

Hopital de Mercy, Ars-Laquenexy

59102

St. Vincent Frontier Cancer Center, Billings

60389

Centrum für Hämatologie und Onkologie Bethanien, Frankfurt

60637

University of Chicago Medical Center, Chicago

63110

Washington University School of Medicine - Siteman Cancer Center, St Louis

64111

Saint Luke's Cancer Institute, Kansas City

66205

The University of Kansas Cancer Center, Westwood

68167

Universitätsmedizin Mannheim, Mannheim

69008

Centre Leon Berard, Lyon

69120

Nationales Centrum für Tumorerkrankungen - Heidelberg, Heidelberg

69310

Hospices Civils de Lyon, Pierre-Bénite

72703

Highlands Oncology Group, Fayetteville

75005

Institut Curie, Paris

75246

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas

75390

University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas

75601

Texas Oncology-Longview Cancer Center, Longview

76210

Texas Oncology-Denton South, Denton

77030

Houston Methodist Hospital/Houston Methodist Cancer Center, Houston

78229

UT Health San Antonio - Mays Cancer Center, San Antonio

80012

Rocky Mountain Cancer Centers, Aurora

80045

University of Colorado, Aurora

84918

Institut Sainte Catherine, Avignon

85392

HonorHealth Research Institute, Avondale

85704

Arizona Oncology Associates, PC, Tucson

90017

Los Angeles Hematology Oncology Medical Group, Los Angeles

90095

UCLA Department of Medicine - Hematology/Oncology, Los Angeles

91054

Universitätsklinikum Erlangen, Erlangen

92093

University of California, San Diego Moores Cancer Center, La Jolla

92120

Southern California Permanente Medical Group, San Diego

92868

University of California, Irvine Medical Center-Chao Family Comprehensive Cancer Center, Orange

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

98405

Northwest Medical Specialties, PLLC, Tacoma

06520

Yale University Cancer Center, New Haven

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

07932

Summit Medical Group, Florham Park

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

Unknown

Chirec Cancer Institute, Brussels

Institut Jules Bordet, Brussels

Universitair Ziekenhuis Leuven, Leuven

CHU UCL Namur/Site Sainte Elisabeth, Namur

Centre Hospitalier de L'Universite de Montreal - Hôpital Notre-Dame, Montreal

Centre Hospitalier Universitaire de Sherbrooke - Fleurimont, Sherbrooke

DIAKOVERE Krankenhaus gGmbH Henriettenstift - Standort Kirchrode, Hanover

Klinikum Mutterhaus der Borromäerinnen, Trier

Azienda Ospedaliera Spedali Civili di Brescia, Brescia

Ospedale Vito Fazzi di Lecce, Lecce

Azienda Ospedaliera San Gerardo di Monza, Monza

Medisch Centrum Haaglanden Antoniushove, Leidschendam

Royal Cornwall Hospital NHS Trust, Cornwell

The Christie NHS Foundation Trust, Manchester

B3H 1V7

Nova Scotia Cancer Centre, Halifax

06847

Städtisches Klinikum Dessau, Dessau

00144

IFO Istituto Nazionale dei Tumori Regina Elena, Rome

08023

Hospital Quirónsalud Barcelona Instituto Oncologico Baselga, Barcelona

08035

Hospital Universitari Vall d'Hebron, Barcelona

08041

Hospital de la Santa Creu I Sant Pau, Barcelona

GU2 7XX

Royal Surrey County Hospital, Guildford

LE1 5WW

Leicester Royal Infirmary, Leicester

EC1A 7BE

Barts Health NHS Trust, London

SW3 6JJ

The Royal Marsden NHS Foundation Trust, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY

NCT03901339 - Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter